Array ( [slideid] => 2 [autoload] => 1 [effect] => scrollUp [speed] => 5000 [width] => 470 [height] => 124 )

Array ( [slideid] => 1 [autoload] => 1 [effect] => fade [speed] => 10000 [width] => 640 [height] => 300 )
  • WSO Newsletter - August 2015

    To read the latest WSO Newsletter, click here
  • World Stroke Day 2015 – The countdown to October 29th is on!

    World Stroke Day 2015 – The countdown to October 29th  is on! This year the World Stroke Campaign will use World Stroke Day to continue to highlight the impact of stroke on women. New brochures and posters will share key messages on the steps women can take to understand and reduce their stroke risk and will call on women to get a health check to avoid preventable stroke. Our brochures will still be used to push home the FAST message, to help ensure that even when stroke strikes, people are aware of the symptoms and can act to save lives and optimise recovery. New ‘I am Woman’ brochures and posters are being prepared and will be available to download from the World Stroke Campaign website soon.  You can also go there to find out more about why we have selected women as the focus for the campaign. Tell us about your World Stroke Day plans If activity in previous years is anything to go by, our supporters are already pulling together exciting and inspiring campaigns for the 29th October. We want to celebrate these efforts and inspire others to get involved by sharing information about World Stroke Day events and activities.  We have set up a page on our website where supporters and partners can share details of their World Stroke Day plans, it has the facility to upload background documents, photos or logo files to help us do your hard work justice. We will publish information on our website and share through our Facebook and twitter platforms. The World Stroke Campaign uses information about World Stroke Day events to help us measure the effectiveness and reach of our campaigns. Please do share information with us about as many events as you can. World Stroke Day Awards Every year we recognise the creativity, hard work and commitment of World Stroke Campaigners around the world.  This year, we have developed our Awards program in response to World Stroke Day World. We have made some changes to the World Stroke Day Awards categories and entry process to find out more and enter for an award visit Winners get free annual membership of the World Stroke Organization and will be invited to receive their awards at the 10th World Stroke Congress in Hyderabad, India in October 2016. We will be sending  out regular e-mail updates to let you know how the campaign is progressing. You can also follow us on Facebook and twitter @WStrokeCampaign the proposed hashtag this year is #WSD2015. For more information and to be added to our mailing list please contact This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Toolkit for the Global Bill of Rights

    Be part of a global campaign to save the 6 million lives lost to stroke and to improve the recovery of 11 million stroke survivors each year. At the heart of this campaign is the Global Stroke Bill of Rights, which sets out aspects of care that are important for ALL stroke survivors and caregivers from across the world. The document was developed by the World Stroke Organization, in partnership with stroke survivors and their caregivers. It sets out the right of each person to: 1.Receive the best stroke care 2.Be informed and prepared 3.Be supported in their recovery How can I use the Stroke Bill of Rights? The Stroke Bill of Rights can help individuals to discuss the care, services and support they need with those providing their care. The document is also an important campaign tool for organzisations when they communicate with stroke care providers and with governments. You can use it to advocate for effective treatment and care and to increase awareness and understanding of what people affected by stroke think are the most important things for their recovery. How can I get involved? Read it! download a copy of the Global Stroke Bill of Rights Sign it! – sign the online petition and join the campaign Share it!– share the document and the petition with your friends, family and networks
  • Alteplase is safe and effective for use within existing treatment guidelines

    Independent expert review concludes alteplase is safe and effective for use within existing treatment guidelines An in-depth independent expert review of a clot-busting drug used in the treatment of acute ischaemic stroke has provided a firm reassurance that it is safe and effective for use – up to 4.5 hours after the onset of symptoms. The earlier the treatment is given the greater the chance of a more favourable outcome for patients. Alteplase acts by breaking down blood clots and can benefit patients by restoring blood flow to areas of the brain that have been affected by a stroke, thereby reducing the risk of long-term disability. An independent expert working group of the UK’s Commission on Human Medicines (CHM) was formed to consider the latest data on the benefits and risks of alteplase in strokes, with a particular focus on the time window for effective treatment. This was in response to questions raised about the evidence base for treatment. The independent scientific group, chaired by Professor Sir Ian Weller, comprised members with expertise in neurology, cardiology, emergency medicine, statistics, epidemiology and patient representation. Following a review of all the latest available evidence the group reached the following conclusions:  The benefit of using alteplase outweighs the risk when used up to 4.5 hours after the onset of symptoms in accordance with the licence. The benefit of alteplase in the treatment of stroke is highly time-dependent and therefore minimising the time to the start of treatment is critical to ensuring the best possible outcome. The latest available data strengthen the existing evidence base for the current authorised use of alteplase.   Professor Sir Ian Weller said: “Patients, the public and healthcare professionals should be reassured that the independent expert working group has rigorously reviewed and discussed all available data and unanimously concluded that alteplase remains safe and effective for use in the treatment of acute ischaemic stroke. “The evidence shows that for every 100 patients treated with alteplase, whilst there is an early risk of a fatal bleed in 2 patients, after three to six months, around 10 more in every 100 are disability free when treated within three hours. In addition 5 more patients in every 100 are disability free when treated between 3 and 4.5 hours after a stroke.  “The conclusion of the group is very clear in that the current timeframe for treatment is supported by strong evidence. The MHRA’s Director of Vigilance and Risk Management of Medicines Dr June Raine said: “A thorough scientific assessment was conducted by staff not involved in the licensing of alteplase. They reviewed all the latest available evidence. We will continue to monitor the safety of alteplase and if any new evidence emerges we will reassess the benefit-risk balance. Patients treated with alteplase should be reassured that this continues to be an effective medicine when used within 4.5 hours after the onset of stroke symptoms.”  Ends  Notes to Editors 1.The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for regulating all medicines and medical devices in the UK by ensuring they work and are acceptably safe. All our work is underpinned by robust and fact-based judgements to ensure that the benefits justify any risks. MHRA is a centre of the Medicines and Healthcare products Regulatory Agency which also includes the National Institute for Biological Standards and Control (NIBSC) and the Clinical Practice Research Datalink (CPRD). The Medicines and Healthcare products Regulatory Agency is an executive agency of the Department of Health.  2.The Commission on Human Medicines (CHM) is a non-departmental public body that advises ministers on the safety, efficacy and quality of medicinal products.    

wsa logo color The World Stroke Academy (WSA) is a elearning portal for the World Stroke Organization (WSO). it provides stroke information on a dynamic, and award-winning online, elerning platform for healthcare professionals with an aim to alleviate the global burden of stroke through the education of stroke practitioners worldwide.
The World Stroke Campaign (WSC) provides education and support for stroke survivors, families and healthcare professional involved in stroke treatment, management and rehabilitation. The primary focus of the WSC is the annual World Stroke Day (WSD), promoting stroke awareness to the international community and working towards pushing stroke to the forefront of the global health agenda.
Hyderabad thumnail Hyderabad, India, October 26- 29, 2016
Through its biennial congresses, the World Stroke Organization (WSO) strives to offer participants opportunities to refine their skills and knowledge in the field of stroke, as well as providing excellent networking opportunities and strengthening scientific collaborations to improve the care of stroke victims throughout the world.
IJS frontcover thumbnail
The International Journal of Stroke (IJS) is the flagship publication of the World Stroke Organization (WSO) and publishes high quality research articles, reviews and clinical trial protocols from around the world. IJS is dedicated to building a global stroke community, making it a global voice for stroke research and an excellent platform for sharing international stroke research.
Stay connected with us through Twitter, the WSO blog, and YouTube!

Stroke Support Organizations have a key role in supporting stroke survivors and their carergivers! Below a message of hope and courage from stroke survivors in the form of artwork.


Your membership makes the difference! Have a look at the video to find out more.